Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of bevacizumab + temozolomide + radiotherapy in newly diagnosed glioblastoma
jRCT2080220804Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Aug 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in glioblastoma (GBM) comparing Bevacizumab arm with Placebo arm (2 arms).
02
Drugs
bevacizumab
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on jRCT2080220804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220804.